ROIV
Roivant Sciences Ltd
40.00$
+1.0%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
Roivant Sciences Ltd (ROIV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -263 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -196 | -210 | -108 | -267 | -267 | -207 | -173 | -204 | -186 | -196 | -164 | -263 | -809 | |
| 7.3 | 5.4 | 2.0 | 4.8 | 4.8 | 2.9 | 1.4 | 1.1 | 0.9 | -8.0 | 30 | 0.6 | 24 | |
| 49 | 54 | 47 | 72 | 72 | 84 | 83 | 82 | 82 | 105 | 77 | 83 | 347 | |
| 90 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 17 | 21 | 16 | 10 | 10 | -53 | 34 | -37 | 7.1 | 9.4 | -601 | 7.1 | -578 | |
| 0.3 | 0.4 | 0.3 | 1.0 | 1.0 | 1.8 | 0.8 | 4.0 | 7.8 | 4.9 | 1.3 | 0.4 | 14 | |
| -36 | 5,233 | 6.9 | -3,294 | -3,294 | 454 | 1,074 | -1,086 | 120 | 149 | 134 | 281 | 685 | |
| 6.0 | – | 6.0 | – | – | – | – | – | – | – | – | – | – | |
| -216 | 0.0 | 222 | -106 | -106 | -243 | -295 | -208 | 0.0 | 0.0 | -111 | -207 | -318 | |
| -7.6 | – | – | – | -1.8 | -49 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | |
| 208 | 237 | -33 | -109 | -109 | -273 | -177 | -188 | 63 | 289 | -30 | -388 | -66 | |
| -26 | 5,262 | -178 | -3,664 | -3,664 | -27 | 724 | -1,477 | -1.4 | 242 | -58 | -370 | -188 | |
| -197 | -211 | -109 | -268 | -268 | -209 | -173 | -208 | -194 | -192 | -165 | -264 | -814 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.